Supplementary Data 2 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers André Oberthuer , Dilafruz Juraeva , Barbara Hero , Ruth Volland , Carolina Sterz , Rene Schmidt , Andreas Faldum , Yvonne Kahlert , Anne Engesser , Shahab Asgharzadeh , Robert Seeger , Miki Ohira , Akira Nakagawara , Paola Scaruffi , Gian Paolo Tonini , Isabelle Janoueix-Lerosey , Olivier Delattre , Gudrun Schleiermacher , Jo Vandesompele , Frank Speleman , Rosa Noguera , Marta Piqueras , Jean Bénard , Alexander Valent , Smadar Avigad , Isaac Yaniv , Richard G. Grundy , Monika Ortmann , Chunxuan Shao , Manfred Schwab , Roland Eils , Thorsten Simon , Jessica Theissen , Frank Berthold , Frank Westermann , Benedikt Brors , Matthias Fischer openalex（2023）
Key words
Neuroblastoma, Risk Classification
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
